Literature DB >> 25627465

Advancing the development of glycated protein biosensing technology: next-generation sensing molecules.

Miho Kameya1, Akane Sakaguchi-Mikami2, Stefano Ferri1, Wakako Tsugawa1, Koji Sode3.   

Abstract

Research advances in biochemical molecules have led to the development of convenient and reproducible biosensing molecules for glycated proteins, such as those based on the enzymes fructosyl amino acid oxidase (FAOX) or fructosyl peptide oxidase (FPOX). Recently, more attractive biosensing molecules with potential applications in next-generation biosensing of glycated proteins have been aggressively reported. We review 2 such molecules, fructosamine 6-kinase (FN6K) and fructosyl amino acid-binding protein, as well as their recent applications in the development of glycated protein biosensing systems. Research on FN6K and fructosyl amino acid-binding protein has been opening up new possibilities for the development of highly sensitive and proteolytic-digestion-free biosensing systems for glycated proteins.
© 2015 Diabetes Technology Society.

Keywords:  biosensing; fructosamine 6-kinase; fructosyl amino acid-binding protein; glycated albumin; glycated protein; hemoglobin A1c

Mesh:

Substances:

Year:  2015        PMID: 25627465      PMCID: PMC4604589          DOI: 10.1177/1932296814565784

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  43 in total

1.  Construction of a fluorescent biosensor family.

Authors:  Robert M de Lorimier; J Jeff Smith; Mary A Dwyer; Loren L Looger; Kevin M Sali; Chad D Paavola; Shahir S Rizk; Shamil Sadigov; David W Conrad; Leslie Loew; Homme W Hellinga
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

2.  DYN 12, a small molecule inhibitor of the enzyme amadorase, lowers plasma 3-deoxyglucosone levels in diabetic rats.

Authors:  F Kappler; M L Schwartz; B Su; A M Tobia; T Brown
Journal:  Diabetes Technol Ther       Date:  2001       Impact factor: 6.118

3.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

4.  Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.

Authors:  B S Szwergold; S Howell; P J Beisswenger
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

5.  Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase.

Authors:  G Delpierre; M H Rider; F Collard; V Stroobant; F Vanstapel; H Santos; E Van Schaftingen
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

6.  Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli.

Authors:  Elsa Wiame; Ghislain Delpierre; Francois Collard; Emile Van Schaftingen
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

7.  Construction of a molecular imprinting catalyst using target analogue template and its application for an amperometric fructosylamine sensor.

Authors:  Koji Sode; Shigenori Ohta; Yoshitsugu Yanai; Tomohiko Yamazaki
Journal:  Biosens Bioelectron       Date:  2003-10-15       Impact factor: 10.618

8.  A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.

Authors:  François Collard; Ghislain Delpierre; Vincent Stroobant; Gert Matthijs; Emile Van Schaftingen
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

9.  Development of a flow-injection analysis (FIA) enzyme sensor for fructosyl amine monitoring.

Authors:  Kinuko Ogawa; Daniela Stöllner; Frieder Scheller; Axel Warsinke; Fumimasa Ishimura; Wakako Tsugawa; Stefano Ferri; Koji Sode
Journal:  Anal Bioanal Chem       Date:  2002-06-06       Impact factor: 4.142

10.  New enzymatic assay for glycohemoglobin.

Authors:  Ikunosuke Sakurabayashi; Tatsurou Watano; Satoshi Yonehara; Kaori Ishimaru; Kaoru Hirai; Tsuguki Komori; Masayuki Yagi
Journal:  Clin Chem       Date:  2003-02       Impact factor: 8.327

View more
  1 in total

Review 1.  The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Authors:  Narasimha M Beeraka; Venugopal R Bovilla; Shalini H Doreswamy; Sujatha Puttalingaiah; Asha Srinivasan; SubbaRao V Madhunapantula
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.